1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2.Distributions of anatomic and procedural data
Variable n (%) Stenosis severity <50% 4 (4) 50%–70% 38 (41) >70% 51 (55) Stenosis <10 mm to bifurcation 58 (62) Presence of coarse calcification 36 (39) Premedication Glycopyrrolate 65 (70) Atropine 8 (9) Both 3 (3) Unknown 17 (18) Number of dilations 0–1 40 (43) 2 35 (38) 3–5 13 (14) Unknown 5 (5) Residual stenosis after stenting 0%–10% 53 (57) 11%–20% 19 (20) 21%–30% 15 (16) 31%–40% 6 (7) Dilation percentage obtained* 10%–39% 12 (13) 40%–69% 39 (42) 70%–99% 42 (45)
* The formula is (stenosis severity percentage before carotid artery stent placement) − (residual stenosis percentage after carotid artery stent placement).